72606-048-01 |
72606-048 |
HUMAN PRESCRIPTION DRUG |
Tocilizumab-anoh |
tocilizumab |
INJECTION, SOLUTION, CONCENTRATE |
INTRAVENOUS |
20250126 |
N/A |
BLA |
BLA761420 |
CELLTRION USA, Inc. |
TOCILIZUMAB |
80 mg/4mL |
1 VIAL, SINGLE-DOSE in 1 CARTON (72606-048-01) / 4 mL in 1 VIAL, SINGLE-DOSE |
72606-048-02 |
72606-048 |
HUMAN PRESCRIPTION DRUG |
Tocilizumab-anoh |
tocilizumab |
INJECTION, SOLUTION, CONCENTRATE |
INTRAVENOUS |
20250126 |
N/A |
BLA |
BLA761420 |
CELLTRION USA, Inc. |
TOCILIZUMAB |
80 mg/4mL |
4 VIAL, SINGLE-DOSE in 1 CARTON (72606-048-02) / 4 mL in 1 VIAL, SINGLE-DOSE |
72606-045-01 |
72606-045 |
HUMAN PRESCRIPTION DRUG |
AVTOZMA |
tocilizumab |
INJECTION, SOLUTION |
INTRAVENOUS |
20250126 |
N/A |
BLA |
BLA761420 |
CELLTRION USA, Inc. |
TOCILIZUMAB |
162 mg/.9mL |
1 SYRINGE, GLASS in 1 CARTON (72606-045-01) / .9 mL in 1 SYRINGE, GLASS |
72606-045-02 |
72606-045 |
HUMAN PRESCRIPTION DRUG |
AVTOZMA |
tocilizumab |
INJECTION, SOLUTION |
INTRAVENOUS |
20250126 |
N/A |
BLA |
BLA761420 |
CELLTRION USA, Inc. |
TOCILIZUMAB |
162 mg/.9mL |
4 SYRINGE, GLASS in 1 CARTON (72606-045-02) / .9 mL in 1 SYRINGE, GLASS |
72606-045-03 |
72606-045 |
HUMAN PRESCRIPTION DRUG |
AVTOZMA |
tocilizumab |
INJECTION, SOLUTION |
INTRAVENOUS |
20250126 |
N/A |
BLA |
BLA761420 |
CELLTRION USA, Inc. |
TOCILIZUMAB |
162 mg/.9mL |
12 SYRINGE, GLASS in 1 CARTON (72606-045-03) / .9 mL in 1 SYRINGE, GLASS |
72606-045-04 |
72606-045 |
HUMAN PRESCRIPTION DRUG |
AVTOZMA |
tocilizumab |
INJECTION, SOLUTION |
INTRAVENOUS |
20250126 |
N/A |
BLA |
BLA761420 |
CELLTRION USA, Inc. |
TOCILIZUMAB |
162 mg/.9mL |
1 SYRINGE, GLASS in 1 CARTON (72606-045-04) / .9 mL in 1 SYRINGE, GLASS |
72606-045-05 |
72606-045 |
HUMAN PRESCRIPTION DRUG |
AVTOZMA |
tocilizumab |
INJECTION, SOLUTION |
INTRAVENOUS |
20250126 |
N/A |
BLA |
BLA761420 |
CELLTRION USA, Inc. |
TOCILIZUMAB |
162 mg/.9mL |
4 SYRINGE, GLASS in 1 CARTON (72606-045-05) / .9 mL in 1 SYRINGE, GLASS |
72606-045-06 |
72606-045 |
HUMAN PRESCRIPTION DRUG |
AVTOZMA |
tocilizumab |
INJECTION, SOLUTION |
INTRAVENOUS |
20250126 |
N/A |
BLA |
BLA761420 |
CELLTRION USA, Inc. |
TOCILIZUMAB |
162 mg/.9mL |
12 SYRINGE, GLASS in 1 CARTON (72606-045-06) / .9 mL in 1 SYRINGE, GLASS |
72606-051-01 |
72606-051 |
HUMAN PRESCRIPTION DRUG |
Tocilizumab-anoh |
tocilizumab |
INJECTION, SOLUTION, CONCENTRATE |
INTRAVENOUS |
20250126 |
N/A |
BLA |
BLA761420 |
CELLTRION USA, Inc. |
TOCILIZUMAB |
162 mg/.9mL |
1 SYRINGE, GLASS in 1 CARTON (72606-051-01) / .9 mL in 1 SYRINGE, GLASS |
72606-051-02 |
72606-051 |
HUMAN PRESCRIPTION DRUG |
Tocilizumab-anoh |
tocilizumab |
INJECTION, SOLUTION, CONCENTRATE |
INTRAVENOUS |
20250126 |
N/A |
BLA |
BLA761420 |
CELLTRION USA, Inc. |
TOCILIZUMAB |
162 mg/.9mL |
4 SYRINGE, GLASS in 1 CARTON (72606-051-02) / .9 mL in 1 SYRINGE, GLASS |
72606-051-03 |
72606-051 |
HUMAN PRESCRIPTION DRUG |
Tocilizumab-anoh |
tocilizumab |
INJECTION, SOLUTION, CONCENTRATE |
INTRAVENOUS |
20250126 |
N/A |
BLA |
BLA761420 |
CELLTRION USA, Inc. |
TOCILIZUMAB |
162 mg/.9mL |
12 SYRINGE, GLASS in 1 CARTON (72606-051-03) / .9 mL in 1 SYRINGE, GLASS |
72606-051-04 |
72606-051 |
HUMAN PRESCRIPTION DRUG |
Tocilizumab-anoh |
tocilizumab |
INJECTION, SOLUTION, CONCENTRATE |
INTRAVENOUS |
20250126 |
N/A |
BLA |
BLA761420 |
CELLTRION USA, Inc. |
TOCILIZUMAB |
162 mg/.9mL |
1 SYRINGE, GLASS in 1 CARTON (72606-051-04) / .9 mL in 1 SYRINGE, GLASS |
72606-051-05 |
72606-051 |
HUMAN PRESCRIPTION DRUG |
Tocilizumab-anoh |
tocilizumab |
INJECTION, SOLUTION, CONCENTRATE |
INTRAVENOUS |
20250126 |
N/A |
BLA |
BLA761420 |
CELLTRION USA, Inc. |
TOCILIZUMAB |
162 mg/.9mL |
4 SYRINGE, GLASS in 1 CARTON (72606-051-05) / .9 mL in 1 SYRINGE, GLASS |
72606-044-01 |
72606-044 |
HUMAN PRESCRIPTION DRUG |
AVTOZMA |
tocilizumab |
INJECTION, SOLUTION |
INTRAVENOUS |
20250126 |
N/A |
BLA |
BLA761420 |
CELLTRION USA, Inc. |
TOCILIZUMAB |
400 mg/20mL |
1 VIAL, SINGLE-DOSE in 1 CARTON (72606-044-01) / 20 mL in 1 VIAL, SINGLE-DOSE |
72606-044-02 |
72606-044 |
HUMAN PRESCRIPTION DRUG |
AVTOZMA |
tocilizumab |
INJECTION, SOLUTION |
INTRAVENOUS |
20250126 |
N/A |
BLA |
BLA761420 |
CELLTRION USA, Inc. |
TOCILIZUMAB |
400 mg/20mL |
4 VIAL, SINGLE-DOSE in 1 CARTON (72606-044-02) / 20 mL in 1 VIAL, SINGLE-DOSE |
72606-051-06 |
72606-051 |
HUMAN PRESCRIPTION DRUG |
Tocilizumab-anoh |
tocilizumab |
INJECTION, SOLUTION, CONCENTRATE |
INTRAVENOUS |
20250126 |
N/A |
BLA |
BLA761420 |
CELLTRION USA, Inc. |
TOCILIZUMAB |
162 mg/.9mL |
12 SYRINGE, GLASS in 1 CARTON (72606-051-06) / .9 mL in 1 SYRINGE, GLASS |
72606-050-01 |
72606-050 |
HUMAN PRESCRIPTION DRUG |
Tocilizumab-anoh |
tocilizumab |
INJECTION, SOLUTION, CONCENTRATE |
INTRAVENOUS |
20250126 |
N/A |
BLA |
BLA761420 |
CELLTRION USA, Inc. |
TOCILIZUMAB |
400 mg/20mL |
1 VIAL, SINGLE-DOSE in 1 CARTON (72606-050-01) / 20 mL in 1 VIAL, SINGLE-DOSE |
72606-050-02 |
72606-050 |
HUMAN PRESCRIPTION DRUG |
Tocilizumab-anoh |
tocilizumab |
INJECTION, SOLUTION, CONCENTRATE |
INTRAVENOUS |
20250126 |
N/A |
BLA |
BLA761420 |
CELLTRION USA, Inc. |
TOCILIZUMAB |
400 mg/20mL |
4 VIAL, SINGLE-DOSE in 1 CARTON (72606-050-02) / 20 mL in 1 VIAL, SINGLE-DOSE |
72606-043-01 |
72606-043 |
HUMAN PRESCRIPTION DRUG |
AVTOZMA |
tocilizumab |
INJECTION, SOLUTION |
INTRAVENOUS |
20250126 |
N/A |
BLA |
BLA761420 |
CELLTRION USA, Inc. |
TOCILIZUMAB |
200 mg/10mL |
1 VIAL, SINGLE-DOSE in 1 CARTON (72606-043-01) / 10 mL in 1 VIAL, SINGLE-DOSE |
72606-043-02 |
72606-043 |
HUMAN PRESCRIPTION DRUG |
AVTOZMA |
tocilizumab |
INJECTION, SOLUTION |
INTRAVENOUS |
20250126 |
N/A |
BLA |
BLA761420 |
CELLTRION USA, Inc. |
TOCILIZUMAB |
200 mg/10mL |
4 VIAL, SINGLE-DOSE in 1 CARTON (72606-043-02) / 10 mL in 1 VIAL, SINGLE-DOSE |